Accanis Biotech F&E GmbH & Co KG
- RDM* biotech/pharma
- Founded in: 2015
- Staff: 14
- Techniques: Cell and tissue culture
- Topic: Human health
- Cluster Membership: LISAvienna
- Profile: What if we could give the body instructions to produce its own drugs? This would be nothing less than a new era in drug therapy and is exactly what messenger RNA (mRNA) could achieve. At ACCANIS, we develop innovative therapeutics for the treatment of common, localized diseases using mRNA. Each cell in your body uses mRNA to translate genetic information into proteins. ACCANIS´ innovative technology takes advantage of this natural mechanism in order to enable effective, on-demand therapeutics.
- R&D: ACCANIS is developing optimized, proprietary in vitro transcribed (IVT) mRNA with broad and long-acting therapeutic potential, surpassing protein-based therapeutics.